Met Life Investment Management, LLC Novo Cure LTD Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Met Life Investment Management, LLC holds 61,603 shares of NVCR stock, worth $1.98 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
61,603
Previous 26,892
129.08%
Holding current value
$1.98 Million
Previous $460,000
109.13%
% of portfolio
0.01%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$389 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$380 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$254 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$138 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$97.3 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.37B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...